OriGene Technologies was founded in 1996 and is headquartered in Rockville, Maryland, USA. It is a globally leading gene-centric life sciences company specializing in genomic and proteomic research tools. The company possesses one of the world’s largest commercial collections of full-length human cDNA clones (over 580,000), and has developed more than one million research products. These include highly validated antibodies (monoclonal and polyclonal), full-length recombinant human proteins (covering over 50% of the human proteome), lentiviruses, CRISPR tools, shRNA, stable cell lines, tissue banks, and custom services. Its mission is to provide high-quality proteins and antibodies—one target at a time—to accelerate scientific breakthroughs and the development of novel diagnostics. For over 25 years, it has served academic institutions, pharmaceutical companies, and diagnostic organizations worldwide.